Erythropoietin doping in cycling: lack of evidence for efficacy and a negative riskbenefit

J.A.A.C. Heuberger, J.M.C. Tervaert, F.M.L. Schepers, A.D.B. Vliegenthart, J.I. Rotmans, J.M.A. Daniels, J. Burggraaf, A.F. Cohen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1406-1421
JournalBritish Journal of Clinical Pharmacology
Volume75
Issue number6
DOIs
Publication statusPublished - 2013

Cite this

Heuberger, J. A. A. C., Tervaert, J. M. C., Schepers, F. M. L., Vliegenthart, A. D. B., Rotmans, J. I., Daniels, J. M. A., ... Cohen, A. F. (2013). Erythropoietin doping in cycling: lack of evidence for efficacy and a negative riskbenefit. British Journal of Clinical Pharmacology, 75(6), 1406-1421. https://doi.org/10.1111/bcp.12034